509 related articles for article (PubMed ID: 187621)
1. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
[TBL] [Abstract][Full Text] [Related]
2. Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism.
Heath H; Purnell DC
J Lab Clin Med; 1980 Dec; 96(6):974-84. PubMed ID: 6253580
[TBL] [Abstract][Full Text] [Related]
3. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
Broadus AE; Mahaffey JE; Bartter FC; Neer RM
J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
[TBL] [Abstract][Full Text] [Related]
5. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
Nussbaum SR; Potts JT
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma.
Fukumoto S; Matsumoto T; Ikeda K; Yamashita T; Watanabe T; Yamaguchi K; Kiyokawa T; Takatsuki K; Shibuya N; Ogata E
Arch Intern Med; 1988 Apr; 148(4):921-5. PubMed ID: 2895617
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
Bill G; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1983 Mar; 113(9):327-30. PubMed ID: 6302835
[TBL] [Abstract][Full Text] [Related]
8. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J
Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265
[No Abstract] [Full Text] [Related]
9. [Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone].
Louboutin JY; Feuillu A; Allain H; Bernat M; Meadeb J; Pawlotsky Y
Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):707-13. PubMed ID: 6256846
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of parathyroid gland function: predictive value of a nomogram].
Villiger L; Eichenberger A; Casez JP; Hess B; Takkinen R; Jaeger P
Schweiz Rundsch Med Prax; 1994 Mar; 83(11):295-9. PubMed ID: 8153507
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
[TBL] [Abstract][Full Text] [Related]
13. A reduced PTH response to hypocalcemia after a short period of hypercalcemia: a study in dogs.
Sánchez J; Aguilera-Tejero E; Estepa JC; Almadén Y; Rodríguez M; Felsenfeld AJ
Kidney Int Suppl; 1996 Dec; 57():S18-22. PubMed ID: 8941917
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.
Suh SM; Tashjian AH; Matsuo N; Parkinson DK; Fraser D
J Clin Invest; 1973 Jan; 52(1):153-60. PubMed ID: 4345201
[TBL] [Abstract][Full Text] [Related]
15. Measurement of parathyroid hormone.
Endres DB; Villanueva R; Sharp CF; Singer FR
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of hypercalcemia.
Lafferty FW
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S51-9; discussion S61. PubMed ID: 1763670
[TBL] [Abstract][Full Text] [Related]
17. Daily follow-up of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism.
Debruyne F; Delaere P; Ostyn F; Van den Bruel A; Bouillon R
J Otolaryngol; 1999 Dec; 28(6):305-8. PubMed ID: 10604157
[TBL] [Abstract][Full Text] [Related]
18. The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia.
Sabour S; Manders E; Steward DL
Otolaryngol Head Neck Surg; 2009 Dec; 141(6):727-9. PubMed ID: 19932845
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
20. Use of C-terminal parathyroid assays in a large metropolitan hospital.
Lum G
Ann Clin Lab Sci; 1985; 15(1):55-60. PubMed ID: 3970518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
